Clinical outcomes in phase 1 clinical trials (Ph1-CT) when treating patients (pts) with novel immunotherapy (IT) agents at early lines for advanced disease-MedSci.cn

Clinical outcomes in phase 1 clinical trials (Ph1-CT) when treating patients (pts) with novel immunotherapy (IT) agents at early lines for advanced disease

Soto, JJ; Llop-Serna, S; Stradella, A; Villanueva, R; Calvo, M; Jove, M; Ruffinelli, JC; Amor, CC; Salazar, R; Gil, MJG; Gil-Martin, M; Oliva, M; Liberal, JM

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):

科室
- - 订阅+
  - 更多科室
工具
服务